No picture, placeholder image
No picture, placeholder image
Det helsevitenskapelige fakultet oystein.k.moe@uit.no Tromsø

Øystein Kittel Moe



  • Øystein Kittel Moe, Qian Gao, Dawei Geng, Einar Jensen, Rasmus Goll, Oddmund Nestegard m.fl.:
    Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study
    BMC Gastroenterology 2025 DOI
  • Rasmus Goll, Øystein Kittel Moe, Kay-Martin Johnsen, Renate Weenås Meyer, Joachim Friestad, Mona Dixon Gundersen m.fl.:
    Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease
    BMC Gastroenterology 2022 DOI / ARKIV
  • Kay-Martin Johnsen, Jon Florholmen, Øystein Kittel Moe, Mona Dixon Gundersen, Julia Beilfuss, Hege Kileng m.fl.:
    Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
    BMC Gastroenterology 2022 DOI / ARKIV
  • Jon Florholmen, Kay-Martin Johnsen, Renate Weenås Meyer, Trine Olsen, Øystein Kittel Moe, Petter Tandberg m.fl.:
    Discovery and validation of mucosal TNF expression combined with histological score-a biomarker for personalized treatment in ulcerative colitis
    BMC Gastroenterology 2020 DOI / ARKIV
  • Rasmus Goll, Richard Heitmann, Øystein Kittel Moe, Carlsen Katrine, Jon Florholmen :
    Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
    PLOS ONE 02. desember 2019 DOI / ARKIV / FULLTEKST

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →